These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 20074168)
1. Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases. Katamura Y; Aikata H; Kimura Y; Kawaoka T; Takaki S; Waki K; Hiramatsu A; Kawakami Y; Takahashi S; Ishikawa M; Hieda M; Kakizawa H; Chayama K J Gastroenterol Hepatol; 2010 Jun; 25(6):1117-22. PubMed ID: 20074168 [TBL] [Abstract][Full Text] [Related]
2. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch. Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshit K; Nakamori S; Monden M Hepatogastroenterology; 2007; 54(73):172-9. PubMed ID: 17419255 [TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis. Eun JR; Lee HJ; Moon HJ; Kim TN; Kim JW; Chang JC Scand J Gastroenterol; 2009; 44(12):1477-86. PubMed ID: 19958061 [TBL] [Abstract][Full Text] [Related]
4. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study. Tanaka K; Yabushita Y; Nakagawa K; Kumamoto T; Matsuo K; Taguri M; Endo I Eur J Surg Oncol; 2013 Dec; 39(12):1364-70. PubMed ID: 24183169 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion. Kasai K; Ushio A; Kasai Y; Sawara K; Miyamoto Y; Oikawa K; Kuroda H; Takikawa Y; Suzuki K Cancer; 2012 Jul; 118(13):3302-10. PubMed ID: 22072099 [TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules. Nagano H; Miyamoto A; Wada H; Ota H; Marubashi S; Takeda Y; Dono K; Umeshita K; Sakon M; Monden M Cancer; 2007 Dec; 110(11):2493-501. PubMed ID: 17941012 [TBL] [Abstract][Full Text] [Related]
7. Similar effects of recombinant interferon-alpha-2b and natural interferon-alpha when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma. Uka K; Aikata H; Takaki S; Miki D; Jeong SC; Hiramatsu A; Kodama H; Shirakawa H; Kawakami Y; Takahashi S; Toyota N; Ito K; Chayama K Liver Int; 2007 Nov; 27(9):1209-16. PubMed ID: 17919232 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of therapy for advanced hepatocellular carcinoma: intra-arterial 5-fluorouracil and subcutaneous interferon with image-guided radiation. Chuma M; Taguchi H; Yamamoto Y; Shimizu S; Nakanishi M; Ogawa K; Sho T; Horimoto H; Kobayashi T; Nakai M; Terashita K; Sakuhara Y; Abo D; Tsukuda Y; Tsunematsu S; Hige S; Kato M; Shirato H; Asaka M J Gastroenterol Hepatol; 2011 Jul; 26(7):1123-32. PubMed ID: 21501224 [TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma. Kuroda M; Kobayashi Y; Urawa N; Yamamoto M; Mifuji R; Araki J; Tanaka H; Horiike S; Itani T; Furjita N; Konishi M; Iwasa M; Kaito M; Adachi Y Hepatogastroenterology; 2007 Mar; 54(74):518-21. PubMed ID: 17523311 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of combined interferon-α and 5-fluorouracil treatment for advanced hepatocellular carcinoma with major portal vein thrombosis. Nagano H; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Tomimaru Y; Osuga K; Umeshita K; Doki Y; Mori M Oncology; 2011; 80(1-2):63-9. PubMed ID: 21659784 [TBL] [Abstract][Full Text] [Related]
11. [A long-term survival case of hepatocellular carcinoma with portal vein and inferior vena cava tumor thrombi]. Hashimoto Y; Wada H; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H Gan To Kagaku Ryoho; 2010 Nov; 37(12):2693-5. PubMed ID: 21224682 [TBL] [Abstract][Full Text] [Related]
12. Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma. Uka K; Aikata H; Takaki S; Miki D; Kawaoka T; Jeong SC; Takahashi S; Toyota N; Ito K; Chayama K J Gastroenterol; 2007 Oct; 42(10):845-53. PubMed ID: 17940838 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study. Niguma T; Mimura T; Tutui N J Hepatobiliary Pancreat Surg; 2005; 12(3):249-53. PubMed ID: 15995815 [TBL] [Abstract][Full Text] [Related]
14. Arterial infusion of 5-fluorouracil combined with subcutaneous injection of pegylated interferon alpha-2b in treating unresectable hepatocellular carcinoma with portal vein tumor thrombus. Wu J; Huang WJ; Wang HY; Wang YF; Peng BG; Zhou Q Med Oncol; 2015 Mar; 32(3):65. PubMed ID: 25691293 [TBL] [Abstract][Full Text] [Related]
15. Hepatic arterial infusion therapy with a fine powder formulation of cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Kondo M; Morimoto M; Numata K; Nozaki A; Tanaka K Jpn J Clin Oncol; 2011 Jan; 41(1):69-75. PubMed ID: 20688778 [TBL] [Abstract][Full Text] [Related]
16. Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-alpha combination therapy following hepatic resection. Wada H; Nagano H; Noda T; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Sakon M; Wakasa K; Monden M J Gastroenterol; 2007 Jun; 42(6):501-6. PubMed ID: 17671767 [TBL] [Abstract][Full Text] [Related]
17. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Chung YH; Song IH; Song BC; Lee GC; Koh MS; Yoon HK; Lee YS; Sung KB; Suh DJ Cancer; 2000 May; 88(9):1986-91. PubMed ID: 10813709 [TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study. Nagamatsu H; Sumie S; Niizeki T; Tajiri N; Iwamoto H; Aino H; Nakano M; Shimose S; Satani M; Okamura S; Kuromatsu R; Matsugaki S; Kurogi J; Kajiwara M; Koga H; Torimura T Cancer Chemother Pharmacol; 2016 Feb; 77(2):243-50. PubMed ID: 26754678 [TBL] [Abstract][Full Text] [Related]
19. Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis. Katamura Y; Aikata H; Takaki S; Azakami T; Kawaoka T; Waki K; Hiramatsu A; Kawakami Y; Takahashi S; Kenjo M; Toyota N; Ito K; Chayama K J Gastroenterol; 2009; 44(5):492-502. PubMed ID: 19330281 [TBL] [Abstract][Full Text] [Related]
20. [Development and research of the new therapy for hepatocellular carcinoma--combined interferon and 5-fluorouracil therapy]. Nagano H; Sakon M; Monden M Nihon Rinsho; 2002 Nov; 60(11):2237-44. PubMed ID: 12440136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]